HCC Trials

Hepatocellular Carcinoma Trials

We have an experienced clinical trials team of doctors, nurses and pharmacists. We offer phase 2 and phase 3 clinical trials in first line and second line therapies including tyrosine kinase inhibitors, Veg F inhibitors and immune check point inhibitors such as PD1, PDL1 and CTLA-4 monoclonal antibodies. We also have access to phase 1 studies conducted by our Oncology colleagues.

All clinical trials are conducted in the state- of- the- art Monash Health Translational Precinct (MHTP).

We provide interpreters for all patients from non English speaking backgrounds

Book your COVID-19 vaccination -Find out more